- $237.20m
- $845.61m
- $798.89m
- 34
- 97
- 63
- 70
Annual income statement for GoHealth, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 877 | 1,062 | 632 | 735 | 799 |
| Cost of Revenue | |||||
| Gross Profit | 678 | 823 | 444 | 576 | 668 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 942 | 1,564 | 950 | 816 | 732 |
| Operating Profit | -64.5 | -501 | -319 | -81.7 | 67 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -97.2 | -534 | -376 | -151 | -5.05 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -97.2 | -534 | -376 | -151 | -7.32 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -44.3 | -189 | -149 | -63.3 | -2.93 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -18.8 | -189 | -149 | -63.3 | -6.59 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -3.26 | 9.87 | -14.2 | -4.75 | -5.13 |